Redwood Grove Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,068
Closed -$3.62M 26
2026
Q1
$3.62M Sell
30,068
-109,600
-78% -$12.7M 1.17% 21
2025
Q4
$14.7M Sell
139,668
-6,700
-5% -$629K 4.19% 12
2025
Q3
$12.3M Buy
146,368
+21,000
+17% +$1.73M 3.52% 15
2025
Q2
$9.92M Hold
125,368
3.29% 21
2025
Q1
$11.3M Sell
125,368
-35,300
-22% -$3.3M 4.03% 12
2024
Q4
$16M Buy
160,668
+10,958
+7% +$1.13M 4.95% 6
2024
Q3
$17M Buy
149,710
+50,410
+51% +$5.99M 4.62% 13
2024
Q2
$12.3M Buy
99,300
+5,300
+6% +$683K 3.85% 16
2024
Q1
$12.4M Buy
94,000
+5,300
+6% +$653K 3.86% 15
2023
Q4
$9.67M Hold
88,700
3.57% 16
2023
Q3
$9.13M Buy
88,700
+5,000
+6% +$539K 3.66% 13
2023
Q2
$9.66M Sell
83,700
-20,000
-19% -$2.27M 4.09% 11
2023
Q1
$11M Sell
103,700
-32,000
-24% -$3.45M 5.25% 5
2022
Q4
$15.1M Hold
135,700
7.48% 1
2022
Q3
$11.7M Hold
135,700
6.42% 3
2022
Q2
$12.4M Hold
135,700
6.73% 3
2022
Q1
$11.3M Hold
135,700
5.63% 7
2021
Q4
$10.4M Buy
135,700
+6,000
+5% +$478K 4.88% 9
2021
Q3
$9.74M Buy
129,700
+25,000
+24% +$1.9M 5.55% 8
2021
Q2
$8.14M Buy
104,700
+50,518
+93% +$3.76M 4.4% 10
2021
Q1
$3.99M Buy
+54,182
New +$4M 2.46% 19

Other funds holding MRK

Redwood Grove Capital's MRK Position: Q2 2026 in Review

Redwood Grove Capital sold out of Merck (MRK) in Q2 2026, closing a stake of 30,068 shares — an estimated $3.62M sold.

Redwood Grove Capital first reported a position in MRK in Q1 2021 and held it in 21 quarters. The position peaked at $17M in Q3 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Redwood Grove Capital reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Redwood Grove Capital sold 30,068 Merck shares in Q2 2026, an estimated $3.62M.
  • Redwood Grove Capital first reported a position in Merck in Q1 2021 and held it in 21 quarters.
  • Redwood Grove Capital's Merck position peaked at $17M in Q3 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Redwood Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.